Connect with us

Press Releases

U.S. Polo Assn. Remains Top 5 Largest Sports Licensor and Top 40 Overall in License Global Magazine’s Prestigious List of Top 150 Global Licensors

Avatar

Published

on

Press Release updated: Aug 25, 2020 09:31 EDT


USPA Global Licensing Inc. (USPAGL) today announced that U.S. Polo Assn., the official brand of the United States Polo Association (USPA), was ranked once again among the elite, as the fifth-largest global sports licensor and 38th overall in License Global magazine’s prestigious list of top 150 global licensors. In addition, the sport-inspired brand placed ninth on the list of fashion apparel licensors. U.S. Polo Assn.’s strong overall ratings come off a record year in 2019 on all fronts, having achieved $1.7 billion in retail sales, expanded its footprint to include over 180 countries and ended with more than 1,100 U.S. Polo Assn. retail stores worldwide.

“Over the past few years, our global team has worked tirelessly to elevate the worldwide presence of our amazing sport-inspired brand. We have aggressively shifted our business model to be more digitally and omni-channel driven while elevating the overall consumer experience. So, to be recognized in License Global’s high-profile list alongside the great sports icons of the National Football League, National Basketball Association, and Major League Baseball is truly an honor,” said J. Michael Prince, President and CEO of USPAGL. “On behalf of U.S. Polo Assn., I want to personally thank our strategic partners and millions of consumers around the world for their unwavering support.”

License Global‘s Top 150 list is a who’s who of licensing titans, derived from an annual study that in their words “accounts for retail sales of licensed merchandise across all major sectors of business, from entertainment to sport, food and beverage, corporate brands, fashion, art and design, and much more.” To be considered for inclusion, each brand or corporate entity must submit retail figures based on worldwide sales of licensed merchandise. In addition, License Global‘s editors do their own independent vetting and verification by consulting industry sources, annual reports and financial documents. The world’s largest brand remains The Walt Disney Company at $54.7 billion in retail sales.

License Global’s Top 10 Sports Licensors:
#1 National Football League
#2 National Basketball Association
#3 Major League Baseball
#4 NFL Players Association
#5 U.S. Polo Assn.
#6 National Hockey League
#7 NASCAR
#8 WWE
#9 PGA Tour
#10 Major League Soccer

U.S. Polo Assn. and USPA Global Licensing Inc. (USPAGL)
U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the nonprofit governing body for the sport of polo in the United States founded in 1890, making it one of the oldest sports governing bodies. With a global footprint of $1.7 billion and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores, department stores, independent retailers and e-commerce, U.S. Polo Assn. offers apparel for men, women and children, as well as accessories, footwear, travel and home goods in 180 countries worldwide. Visit https://uspoloassnglobal.com/

USPA Global Licensing Inc. (USPAGL) is the for-profit subsidiary of the USPA and the exclusive worldwide licensor for the USPA’s global licensing program. USPAGL manages the global, multi-billion-dollar U.S. Polo Assn. brand and is the steward of the USPA’s intellectual properties, providing the sport with a long-term source of revenue. USPAGL also produces global broadcasts to bring the sport of polo to consumers and sports fans around the world including the GAUNTLET OF POLO, the sport’s professional, high-goal $1 million prize money series played on U.S. Polo Assn. Field at International Polo Club Palm Beach (IPC).

Contact:
Stacey Kovalsky – Senior Director, Global Communications
Phone +001.561.790.8036 – E-mail: skovalsky@uspagl.com

Source: U.S. Polo Assn.

Source: https://www.newswire.com/news/u-s-polo-assn-remains-top-5-largest-sports-licensor-and-top-40-overall-21198197

Continue Reading

Press Releases

TES Invests In Green Li-ion’s Cutting Edge Battery Recycling Technology

Avatar

Published

on

Press Release updated: Oct 26, 2020 12:37 +08


Today, TES announced a strategic investment in Green Li-ion, a start-up technology innovator based in Singapore focused on creating sustainable models for battery recycling. This investment is aimed at extending Green Li-ion’s proprietary battery recycling technology to TES’s suite of battery recycling solutions.

Green Li-ion’s technology will be integrated into TES’s existing battery recycling facilities. Their Multi-Cathode processor and control unit GLMC-1 will give TES the in-house capability to further refine lithium iron phosphate batteries. It will also deliver higher purity rates on commodities like graphite and cathode metal salts (e.g. LiCo1/3Ni1/3Mn1/3O2, NiCO3, MnCO3, CoC2O4, and Li2CO3), as well as cobalt and lithium extracted from lithium-ion batteries.

“With this investment, TES reaffirms its commitment to offering innovative, world-leading circular outcomes to our clients all over the world,” said Gary Steele, TES’s Chief Executive Officer. “Green Li-ion’s technology in our facility revolutionises battery recycling and enables the supply chain to access high purity recovered commodities,” he said.

“The precious metals used to manufacture lithium-ion batteries are often mined in socially and environmentally damaging ways and the reason why they are not recycled is that it is simply not economical to do so with the current technology,” said Leon Farrant, Green Li-ion’s Chief Executive Officer. He continued, “Green Li-ion technology changes this by removing inefficient processes and improving the purity of the output, making lithium-ion battery rejuvenation and reuse a new reality.”

By leveraging Green Li-ion’s technology, TES’s battery recycling process will yield the highest commodity-grade recovery rates in the industry. All recovered materials will ultimately be reused in the forward manufacturing supply chain and contribute to the circular economy. TES was recently recognised by Reuters’ Responsible Business Awards in the ‘Sustainability Innovation’ category. According to Reuters, the recognition is for companies that have championed innovation in a sustainability initiative enabled by technology. TES stood out among formidable competitors such as UPS, Kraft Heinz, Maersk and Formula One. Winners in other categories included Coca-Cola, Goldman Sachs, Dow, and Verizon, to name a few.

Safety issues, transboundary movements, hazardous waste designations, and the efficient/effective processing of batteries are challenges that are not going away anytime soon. This investment positions TES as a leader in the growing battery recycling space and, at the same time, helps our clients manage the challenges and risks that are inherent to them.

About TES

Founded in 2005, TES is a circular economy leader focused on helping customers with the commissioning, deployment, and retirement of IT assets. As one of the world’s largest providers of IT lifecycle services, TES understands the common challenges faced when managing IT equipment through its lifecycle, and our bespoke, cost-effective solutions address these challenges while achieving compliance with all local and international data security, environmental, and industry regulations.

TES is backed by Navis Capital Partners, one of the largest private equity companies in Southeast Asia, with more than US$6 billion under management. TES has an unmatched global footprint and operates 40 locations across 20 countries with more than 1,700 employees. Our mission is to create outstanding value for our customers, employees and stakeholders, as well as the global community by leveraging our unique combination of security, value recovery, and environmental expertise.

Find out more at www.tes-amm.com.

About Green Li-ion

Green Li-ion is revolutionising the energy storage industry with the world’s first deep-clean technology that fully rejuvenates lithium-ion batteries. Green Li-ion solves the existential risk to the precious metals industry and the environment. It is cleaner, faster, and 4x more profitable than current market leaders.

For two decades, lithium-ion batteries have been our preferred source of portable energy, but the sad reality is that with a lifespan of only 1-3 years, up to 95% of these batteries end up in dangerous landfills.

The precious metals used to manufacture lithium-ion batteries are often mined in socially and environmentally damaging ways and the reason why they are not recycled is that it is simply not economical to do so with the current technology. Green Li-ion technology changes this by removing 1-3 inefficient processes and improving the purity of the output, making lithium-ion battery rejuvenation and reuse a new reality.

Green Li-ion’s hardware technology, Multi-Cathode processor and control unit GLMC-1, enhance current lithium-ion battery recycling lines to produce 99.9% pure cathodes. In turn, this leads to 4x the profits with an 8x reduced carbon footprint for e-recyclers and lithium-ion battery recyclers.

Find out more at https://www.greenli-ion.com.

Source: TES

Source: https://www.newswire.com/news/tes-invests-in-green-li-ions-cutting-edge-battery-recycling-technology-21243167

Continue Reading

Press Releases

New Data On Mayne Pharma’s Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020

ADELAIDE, Australia, Oct. 26, 2020 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that new clinical data has been presented on TOLSURA® (SUBA®-itraconazole) at IDWeek 2020, being held virtually in the US from October 21st-25th. The conference is attended by…

Avatar

Published

on

ADELAIDE, Australia, Oct. 26, 2020 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that new clinical data has been presented on TOLSURA® (SUBA®-itraconazole) at IDWeek 2020, being held virtually in the US from October 21st-25th. The conference is attended by over 11,500 doctors and other healthcare professionals. During the conference there were several oral presentations describing the clinical attributes of TOLSURA.

The key presentation was the publication of data from the Investigator Initiated trial conducted by the Mycoses Study Group titled “SUBA-itraconazole versus conventional itraconazole in the treatment of endemic mycoses: a multi-centre, open-label, randomized comparative trial“[1]. The study is a head-to-head, randomised controlled trial to investigate TOLSURA (SUBA-itraconazole) versus conventional oral itraconazole capsules in the treatment of endemic fungal infections. Patients enrolled in the study had proven or probable invasive endemic fungal infections, with the trial designed to ascertain the pharmacokinetics, safety, efficacy, tolerability and health economics of TOLSURA compared to conventional itraconazole capsules.

The study results were presented by the study Principal Investigator, Professor Peter G. Pappas, MD. The pharmacokinetic data described showed that TOLSURA delivers itraconazole serum levels which consistently exceed those of the conventional itraconazole group even though it is dosed with 35% less drug. The higher serum levels with TOLSURA were recorded at each timepoint throughout the study and there was no increase in occurrence of common adverse events. Gastrointestinal adverse events were more prevalent in the conventional itraconazole group (26%) than the TOLSURA group (13%). It was also noted that the TOLSURA formulation allows for dosing independent of food and gastric acid, a significant point of differentiation versus other itraconazole formulations.

Professor Pappas concluded that “TOLSURA is safe, well-tolerated, and consistently leads to combined serum itraconazole levels that are higher when compared to conventional itraconazole capsules. Moreover, compared to conventional itraconazole, TOLSURA achieves these serum levels when administered at substantially lower daily doses”.

Mayne Pharma’s CEO Scott Richards said, “This is the first major endemic mycoses study in the US for over 20 years and provides the first controlled study in both histoplasmosis and blastomycosis patients for nearly 30 years. These data demonstrate the major clinical attributes of TOLSURA with the product consistently delivering serum levels higher than conventional itraconazole, in combination with a good safety profile. As a controlled, head-to-head study, these data provide real-world clinical evidence of the utility of TOLSURA in endemic infections.”

The oral presentations at IDWeek 2020 relating to TOLSURA are:

About IDWeek 
IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS) and the Society of Infectious Diseases Pharmacists (SIDP). IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases, including HIV, across the lifespan. For more information, visit www.idweek.org

For more information, including a complete list of abstracts, please visit:
https://www.eventscribe.com/2020/IDWeek/index.asp 

About Mayne Pharma
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialise branded and generic pharmaceuticals, offering patients better and more accessible medicines. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.

Mayne Pharma has a 40-year track record of innovation and success in developing new oral drug delivery systems and these technologies have been successfully commercialised in numerous products that continue to be marketed around the world.

Mayne Pharma has two facilities based in Salisbury, Australia and Greenville, USA with expertise in the formulation of complex oral and topical dose forms including potent compounds, modified-release products and poorly soluble compounds.

Please see full Prescribing Information by visiting TOLSURA.com.

1 ClinicalTrials.gov Identifier: NCT03572049

SOURCE Mayne Pharma

Related Links

www.maynepharma.com

Source: https://www.prnewswire.com:443/news-releases/new-data-on-mayne-pharmas-tolsura-suba-itraconazole-presented-at-idweek-2020-301159299.html

Continue Reading

Press Releases

Consumer Priorities Are the Key to Solving Urban Mobility

MUNICH, Oct. 26, 2020 Cities will need to orchestrate their transportation systems to prevent them from collapsing under the strain of growing demand and competing mobility modes. But for urban mobility to be truly effective, municipal authorities should place consumer priorities at the…

Avatar

Published

on

MUNICH, Oct. 26, 2020  Cities will need to orchestrate their transportation systems to prevent them from collapsing under the strain of growing demand and competing mobility modes. But for urban mobility to be truly effective, municipal authorities should place consumer priorities at the heart of their plans, according to a new report from Boston Consulting Group (BCG). The report, Solving the Mobility Challenge in Megacities, is being released today.

Research Points to Three Main Priorities

BCG questioned more than 2,000 people in Beijing, Boston, London, and Moscow about their mobility priorities in late 2019, prior to the pandemic. “Megacities today are swamped with rival mobility offerings as multiple players compete for market share. Municipal authorities need to bring order to this chaos. But first, they must understand what consumers want from urban mobility. Our research suggests this comes down to three key elements,” said Nikolaus Lang, a BCG managing director and senior partner, and leader of the firm’s Global Advantage practice worldwide.

The priorities are:

  • Productivity and Multitasking. Consumers want to use their time in transit for work and entertainment.
  • Independence. Flexible schedules and on-demand mobility are key.
  • Sustainability. Environmentally sustainable transport solutions are important differentiators for many consumers, especially millennials.

Significantly, most respondents said cost of travel, ease of use (for example, simple ticketing processes), and comfort were less important to them.

While COVID-19 has altered mobility decisions in the short term—with consumers more inclined to use private cars because they offer greater protection against the virus than shared forms of mobility—BCG believes the findings will hold true over the medium to longer term. Indeed, these findings should inform cities’ strategies as they work toward more integrated and effective urban transportation systems.

“Rapid urbanization is placing transportation systems under huge strain. Inadequate mobility leads to greater congestion and reduced productivity, but it is also a significant cause of poor health and social inequality. These problems are particularly acute in megacities,” said Alexander Wachtmeister, a managing director and senior partner in the firm’s Munich office.

Contrary to the often-touted shift away from car ownership that dominates much public debate, survey respondents expressed a growing desire to own a car. But the main reasons given for car ownership were practical concerns (including speed and flexibility) and necessity (due to a lack of better alternatives), rather than personal preferences (such as emotional attachment, the car’s importance as a status symbol, or the joy of driving). This suggests that consumers are willing to give up their vehicles provided cities create more effective transportation systems to take their place.

No-Regrets Moves for a Successful Mobility Future

BCG’s research found that emerging mobility options like ride hailing and micromobility are an improvement on traditional cars and mass transit when it comes to meeting consumers’ mobility priorities. But they solve only some user paint points. E-scooters, for example, offer consumers greater independence and an enjoyable, leisurely travel experience (provided the weather is fair). Still, e-scooters face sustainability challenges arising from their relatively short lifespans and safety concerns as well as the need for vehicle collection and charging.

In the city of the future, an orchestrator will be needed to impartially coordinate the activities of mobility operators in order to produce the best overall outcome for consumers. And cities will have to make fundamental changes in how transportation systems are organized and develop mobility management systems as well as digital customer platforms if they are to deliver more consumer-centric solutions.

To maximize the opportunities ahead, city planners and private players should pursue a number of no-regrets moves. They should define their ambition, invest in new competencies, develop partnership arrangements, and, in the case of companies, create effective governance for business units focused on the latest mobility-related areas.

A copy of the report can be downloaded here.

To arrange an interview with one of the authors, please contact Eric Gregoire at +1 617 850 3783 or [email protected].

About Boston Consulting Group
Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we help clients with total transformation—inspiring complex change, enabling organizations to grow, building competitive advantage, and driving bottom-line impact.

To succeed, organizations must blend digital and human capabilities. Our diverse, global teams bring deep industry and functional expertise and a range of perspectives to spark change. BCG delivers solutions through leading-edge management consulting along with technology and design, corporate and digital ventures—and business purpose. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, generating results that allow our clients to thrive.

SOURCE Boston Consulting Group (BCG)

Related Links

www.bcg.com

Source: https://www.prnewswire.com:443/news-releases/consumer-priorities-are-the-key-to-solving-urban-mobility-301159149.html

Continue Reading
Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Saas1 min ago

Press Releases18 mins ago

TES Invests In Green Li-ion’s Cutting Edge Battery Recycling Technology

Press Releases45 mins ago

New Data On Mayne Pharma’s Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020

Startup45 mins ago

Tesla recalls nearly 50,000 Model S and X cars exported to China due to safety concerns over faulty suspensions

Press Releases54 mins ago

BCG and Microsoft Collaborate to Launch BCG’s Catalyst Cloud Solution on Azure, a New Scalable and Extensible Data Platform for the Bionic Corporation

Press Releases54 mins ago

The Rockefeller Foundation commits USD1 billion to catalyze a green recovery from pandemic

Press Releases54 mins ago

Consumer Priorities Are the Key to Solving Urban Mobility

Press Releases1 hour ago

WAAREE déploie ses ailes au niveau mondial et ouvre un franchisé en Afrique

Venture Capital2 hours ago

Agile insurtechs respond to crisis opportunities

Venture Capital2 hours ago

Fatfish Group completes capital raise and plans to further develop its fintech ventures

Venture Capital3 hours ago

Zip Co acquires fashion search engine The Urge

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Saas3 hours ago

Press Releases4 hours ago

Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies

Private Equity4 hours ago

Gulf Capital backs CWB as part of $60mln IP platform build

Private Equity4 hours ago

Allianz-managed AfricaGrow backs first two funds

Private Equity4 hours ago

Lilium Capital’s Vista Bank acquires two BNP units

Private Equity4 hours ago

Secha Capital holds first close for $30mln impact fund

Private Equity4 hours ago

Gaia lists infrastructure fund on South Africa’s 4AX

Venture Capital5 hours ago

Societal shift away from cash sends Novatti transaction volumes soaring

Press Releases5 hours ago

BIG NEWS: Endangered White Rhino Born at Disney’s Animal Kingdom Theme Park

Private Equity7 hours ago

No title

Saas7 hours ago

Trending